These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11052667)

  • 1. Localization of the binding site for the oligosaccharide moiety of Gb3 on verotoxin 1 using NMR residual dipolar coupling measurements.
    Thompson GS; Shimizu H; Homans SW; Donohue-Rolfe A
    Biochemistry; 2000 Oct; 39(43):13153-6. PubMed ID: 11052667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solution structure of the complex between the B-subunit homopentamer of verotoxin VT-1 from Escherichia coli and the trisaccharide moiety of globotriaosylceramide.
    Shimizu H; Field RA; Homans SW; Donohue-Rolfe A
    Biochemistry; 1998 Aug; 37(31):11078-82. PubMed ID: 9693003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A verotoxin 1 B subunit-lambda CRO chimeric protein specifically binds both DNA and globotriaosylceramide (Gb(3)) to effect nuclear targeting of exogenous DNA in Gb(3) positive cells.
    Facchini LM; Lingwood CA
    Exp Cell Res; 2001 Sep; 269(1):117-29. PubMed ID: 11525645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of the binding site for modified Gb3 on verotoxin 1 using fluorescence analysis.
    Picking WD; McCann JA; Nutikka A; Lingwood CA
    Biochemistry; 1999 Jun; 38(22):7177-84. PubMed ID: 10353828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different binding property of verotoxin-1 and verotoxin-2 against their glycolipid receptor, globotriaosylceramide.
    Itoh K; Tezuka T; Inoue K; Tada H; Suzuki T
    Tohoku J Exp Med; 2001 Dec; 195(4):237-43. PubMed ID: 11908825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential carbohydrate epitope recognition of globotriaosyl ceramide by verotoxins and a monoclonal antibody.
    Chark D; Nutikka A; Trusevych N; Kuzmina J; Lingwood C
    Eur J Biochem; 2004 Jan; 271(2):405-17. PubMed ID: 14717708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of the shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3.
    Ling H; Boodhoo A; Hazes B; Cummings MD; Armstrong GD; Brunton JL; Read RJ
    Biochemistry; 1998 Feb; 37(7):1777-88. PubMed ID: 9485303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential intracellular transport and binding of verotoxin 1 and verotoxin 2 to globotriaosylceramide-containing lipid assemblies.
    Tam P; Mahfoud R; Nutikka A; Khine AA; Binnington B; Paroutis P; Lingwood C
    J Cell Physiol; 2008 Sep; 216(3):750-63. PubMed ID: 18446787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-assembled monolayers of globotriaosylceramide (Gb3) mimics: surface-specific affinity with shiga toxins.
    Miura Y; Sasao Y; Dohi H; Nishida Y; Kobayashi K
    Anal Biochem; 2002 Nov; 310(1):27-35. PubMed ID: 12413469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of binding platforms yields insights into receptor binding differences between shiga toxins 1 and 2.
    Flagler MJ; Mahajan SS; Kulkarni AA; Iyer SS; Weiss AA
    Biochemistry; 2010 Mar; 49(8):1649-57. PubMed ID: 20092352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mutational analysis of the globotriaosylceramide-binding sites of verotoxin VT1.
    Soltyk AM; MacKenzie CR; Wolski VM; Hirama T; Kitov PI; Bundle DR; Brunton JL
    J Biol Chem; 2002 Feb; 277(7):5351-9. PubMed ID: 11723119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling of the interaction of verotoxin-1 (VT1) with its glycolipid receptor, globotriaosylceramide (Gb3).
    Nyholm PG; Brunton JL; Lingwood CA
    Int J Biol Macromol; 1995 Jun; 17(3-4):199-204. PubMed ID: 7577818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The identification of three biologically relevant globotriaosyl ceramide receptor binding sites on the Verotoxin 1 B subunit.
    Bast DJ; Banerjee L; Clark C; Read RJ; Brunton JL
    Mol Microbiol; 1999 Jun; 32(5):953-60. PubMed ID: 10361298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apparent cooperativity in multivalent verotoxin-globotriaosyl ceramide binding: kinetic and saturation binding studies with [(125)I]verotoxin.
    Peter MG; Lingwood CA
    Biochim Biophys Acta; 2000 Jun; 1501(2-3):116-24. PubMed ID: 10838185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adamantyl globotriaosyl ceramide: a monovalent soluble mimic which inhibits verotoxin binding to its glycolipid receptor.
    Mylvaganam M; Lingwood CA
    Biochem Biophys Res Commun; 1999 Apr; 257(2):391-4. PubMed ID: 10198223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic analyses of bindings of Shiga-like toxin to clustered and dispersed Gb3 glyco-arrays on a quartz-crystal microbalance.
    Mori T; Ohtsuka T; Okahata Y
    Langmuir; 2010 Sep; 26(17):14118-25. PubMed ID: 20666463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multivalent inhibition of AB(5) toxins.
    Gargano JM; Ngo T; Kim JY; Acheson DW; Lees WJ
    J Am Chem Soc; 2001 Dec; 123(51):12909-10. PubMed ID: 11749553
    [No Abstract]   [Full Text] [Related]  

  • 18. Phenylalanine 30 plays an important role in receptor binding of verotoxin-1.
    Clark C; Bast D; Sharp AM; St Hilaire PM; Agha R; Stein PE; Toone EJ; Read RJ; Brunton JL
    Mol Microbiol; 1996 Feb; 19(4):891-9. PubMed ID: 8820657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycolipid receptors for verotoxin and Helicobacter pylori: role in pathology.
    Lingwood CA
    Biochim Biophys Acta; 1999 Oct; 1455(2-3):375-86. PubMed ID: 10571026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of tether length in nonglycosidically linked bivalent ligands that target sites 2 and 1 of a Shiga-like toxin.
    Kitov PI; Shimizu H; Homans SW; Bundle DR
    J Am Chem Soc; 2003 Mar; 125(11):3284-94. PubMed ID: 12630884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.